These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6934003)

  • 1. Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia.
    Pinkerton CR; Welshman SG; Dempsey SI; Bridges JM; Glasgow JF
    Br J Cancer; 1980 Oct; 42(4):613-5. PubMed ID: 6934003
    [No Abstract]   [Full Text] [Related]  

  • 2. Enterotoxic effect of methotrexate: does it influence the drug's absorption in children with acute lymphoblastic leukaemia?
    Pinkerton CR; Glasgow JF; Bridges JM; Welshman SG
    Br Med J (Clin Res Ed); 1981 Apr; 282(6272):1276-7. PubMed ID: 6784815
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of oral methotrexate absorption in children with leukemia.
    Mahony MJ; Murphy MS; Wadsworth J; Mott MG
    Cancer Chemother Pharmacol; 1984; 12(2):131-3. PubMed ID: 6583027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?
    Pinkerton CR; Welshman SG; Glasgow JF; Bridges JM
    Lancet; 1980 Nov; 2(8201):944-6. PubMed ID: 6107590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia.
    Pearson AD; Craft AW; Eastham EJ; Aherne GW; Littleton P; Pearson GL; Campbell AN
    Cancer Chemother Pharmacol; 1985; 14(3):211-5. PubMed ID: 3858014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate absorption in children with acute lymphoblastic leukemia.
    Craft AW; Rankin A; Aherne W
    Cancer Treat Rep; 1981; 65 Suppl 1():77-81. PubMed ID: 6948609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of co-trimoxazole on methotrexate pharmacokinetics in children with acute lymphoblastic leukemia.
    Beach BJ; Woods WG; Howell SB
    Am J Pediatr Hematol Oncol; 1981; 3(2):115-9. PubMed ID: 6975580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia.
    Pinkerton CR; Welshman SG; Kelly JG; Shanks RG; Bridges JM
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):36-9. PubMed ID: 6961972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of systemic clearance of methotrexate in acute lymphoid leukemia in childhood].
    Borsi J; Révész T; Schuler D
    Orv Hetil; 1986 Feb; 127(8):439-42. PubMed ID: 3456552
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.
    Pearson AD; Mills S; Amineddine HA; Long DR; Craft AW; Chessells JM
    Cancer Chemother Pharmacol; 1987; 20(3):243-7. PubMed ID: 3315283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
    Craft AW; Kay H; Lawson DN; McElwain TJ
    Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
    Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
    Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel function in acute lymphoblastic leukaemia.
    Pearson AD; Craft AW; Pledger JV; Eastham EJ; Laker MF; Pearson GL
    Arch Dis Child; 1984 May; 59(5):460-5. PubMed ID: 6428327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia.
    Borsi JD; Revesz T; Schuler D
    Cancer Chemother Pharmacol; 1987; 19(3):261-4. PubMed ID: 3472677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of childhood acute lymphoblastic leukemia based on the pharmacokinetics of methotrexate in serum and cerebrospinal fluid.
    Muchi H; Ijima H; Karube T
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1397-408. PubMed ID: 3867213
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.
    Borsi JD; Moe PJ
    Cancer; 1987 Jul; 60(1):5-13. PubMed ID: 3472638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intermediate dose methotrexate in patients of non-Hodgkin's lymphoma and acute lymphocytic leukaemia.
    Gadgil SD; Damle SR; Shetty PA; Jussawalla DJ
    Indian J Cancer; 1980 Sep; 17(3):176-8. PubMed ID: 6936382
    [No Abstract]   [Full Text] [Related]  

  • 18. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.
    Gwavava NJ; Pinkerton CR; Glasgow JF; Sloan JM; Bridges JM
    J Clin Pathol; 1981 Jul; 34(7):790-5. PubMed ID: 6943149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Massive dose methotrexate with citrovorum factor rescue: MTX-pharmacokinetics, excretion pattern, and techniques for safety administration (author's transl)].
    Sasaki K; Fujimoto T
    Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):988-96. PubMed ID: 317293
    [No Abstract]   [Full Text] [Related]  

  • 20. Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia.
    Pinkerton CR; Cameron CH; Sloan JM; Glasgow JF; Gwevava NJ
    J Clin Pathol; 1982 Nov; 35(11):1272-7. PubMed ID: 6958682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.